Ticker TARA – Artara Therapeutics Inc – sales, description, marketcap – Tickerday.com

TARA

Artara Therapeutics Inc

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 176.18M; Volume: 9.68K; AvgVol 3m: 32.72K; Beta: 0.93;

Cost estimate:

P/E: –; EPS: -9.22; EPS growth quarter/prev quarter: 88.70%;

EPS growth this year: 34.20%; EPS growth past 5 years: 24.90%;

EPS ttm: -9.22;

P/S: ; P/B: 02.02; P/Cashflow: ; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -54.30%; ROE – return on equity: -82.20%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.02;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 5.60%; Insider Transactions:109.05%;

Institutional Ownership: 38.10%; Institutional Transactions: 0.57%;

Data update: 07/10/2020.